Dr. Zhang received his MD from Peking Union Medical College, Tsinghua University, where his work focused on improving the microenvironments of myocardial infarction. After graduation, Dr. Zhang completed his residency and cardiac fellowship in Fuwai Hospital.

He then pursued Postdoctoral training at Stanford University in Joseph Wu’s lab. There he has developed antifibrotic therapies using human iPSC platforms, animal models, and in silico-based drug development.

discover our innovative technology

Be a part of an ambitious team with limitless potential

Do you want to be a part of an innovative company that helps patients? If you share our vision contact us.

Scroll to Top